Skip to content
Open access

SeqUIaSCOPE: multi-omics data integration platform for single-patient clinical oncology pathway exploration

Aug 2026 · Bioinformatics · Vol 42 · 0 citations · 9 references
Medicine

TL;DR

The SeqUIaSCOPE platform combines molecular-level validation via embedded genome browsing with systems-level interpretation through dynamic pathway visualization, enabling geneticists to assess how alterations converge across biological networks.

Abstract

Abstract Summary SeqUIaSCOPE is an open-source platform designed for routine clinical oncology diagnostics through case-centric integration and visualization of genomic variants, fusion events, and expression profiles. The platform combines molecular-level validation via embedded genome browsing with systems-level interpretation through dynamic pathway visualization, enabling geneticists to assess how alterations converge across biological networks. Flexible reporting with customizable templates accommodates diverse institutional requirements, while secure cluster-based or local deployment ensures compliance with data protection policies, making advanced multi-omics diagnostics accessible to academic and clinical institutions. Availability and Implementation SeqUIaSCOPE is freely available on GitHub at https://github.com/BioIT-CEITEC/sequiascope under the MIT license and archived at Zenodo (https://zenodo.org/records/21338445). Due to the sensitive nature of patient data, the repository provides simulated datasets that mimic the structure of real clinical data for testing and exploration. Documentation and a live demo accompany these datasets, allowing users to explore the application without any prior setup. The repository also includes a Helm chart for Kubernetes deployment and Docker containers for local deployment, ensuring compatibility across Linux, macOS, and Windows. No user registration is required, and all data remains on local or institutional infrastructure.

Read PDF

Similar papers

Open access Aug 2026

The GENIE Data Model: A Solid Tumor, Person-Centric Framework for Scalable, Harmonized Precision Oncology Data Collection

The GENIE Data Model (GDM), a comprehensive, open-source, oncology data model for scalable, consistent, and interoperable data collection across solid tumors designed to effectively capture the patient's journey with cancer, is developed.

J. Hoppe, Jocelyn Lee, T. Akinyemiju et al. · 0 citations
Sep 2026

NeuroGeno3D: A unified clinical decision support system integrating structural biology, molecular interpretation, and clinical evidence for precision neuro-oncology.

Translating genetic variations into clinically useful molecular interpretations in neuro-oncology remains difficult, requiring physicians to examine many databases and resources. We created NeuroGeno3D, a browser-based clinical decision support platform that combines structural bioinformatics, molecular pathology, and...

Rijhul Lahariya, Mainak Sinha, A. Das et al. · 0 citations
Open access Sep 2026

TISON: A Web Server for Omics-driven Integrative Cancer Modeling & Simulations towards Personalized Medicine.

Next-generation sequencing (NGS) has catalyzed the generation of individualized multi-omics datasets, potentiating precise molecular insights into cancer initiation, progression, and metastasis. The subsequent data analytics have necessitated the development of computational pipelines that couple patient-specific omics...

Zainab Nasir, M. U. Sultan, M. Gondal et al. · 0 citations
Open access Aug 2026

RedFuMOS: A novel approach for multi-omics and clinical data-driven patient stratification

RedFuMOS provides a flexible framework for integrating heterogeneous multi-omics and clinical data and includes a dimensionality reduction step to mitigate the curse of dimensionality, which confirmed that, although computationally expensive, the dimensionality reduction step is crucial for achieving good stratificatio...

S. De Luca, C. Fava, G. Rizzo et al. · 0 citations
Open access Sep 2026

Decentralizing Clinical Tumor Exome Analysis: On-Premises GPU-Based Secondary Analysis in a Clinical Molecular Laboratory

Background/Objectives: Clinical tumor sequencing has become central to precision oncology, yet secondary genomic analysis remains heavily dependent on cloud or centralized computational infrastructure, creating barriers related to cost, turnaround time, data governance, and accessibility. We demonstrate that secondary...

P. Ahluwalia, Denton Lord, Mason R. Arbery et al. · 0 citations
Review Aug 2026

Clinical Variant Interpretation with the Integrative Genomics Viewer (IGV) for Molecular Pathologists.

The integrative genomics viewer (IGV) is a pivotal tool in clinical genomics, enabling the visualization and interpretation of complex sequencing data. Bringing clinical knowledge to bear with visual evaluation of sequencing results is the primary means by which molecular pathologists and other professionals assess and...

E. Halper-Stromberg, Suguna P. Narayan, V. Laufer et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.